Back

Common genetic variants associated with characteristics and clinical outcomes of atrial fibrillation: from a large population based registry (FinnGen)

29 August 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Prediction of atrial fibrillation recurrences: still a challenge Genetic Aspects of Arrhythmias ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Abhishek Maan

University of Toledo, Toledo (United States of America)

6 More presentations in this session

Presentation thumbnail
How does artificial intelligence-derived electrocardiographic age and sex predict recurrence outcomes after atrial fibrillation catheter ablation?
Doctor H. Park (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
The role of pulmonary vein anatomy in predicting atrial arrhythmia recurrence after pulsed-field ablation
Mr M. Mutti (Basel, CH)
Abstract Slides Video
Presentation thumbnail
The impact of atrial fibrillation progression on the epicardial adipose tissue volume: supporting 'AF begets EAT' theory
Doctor K. Shimojo (Ogaki, JP)
Abstract Slides Video
Presentation thumbnail
Impact of low hemoglobin levels on arrhythmia recurrence after radiofrequency catheter ablation of atrial fibrillation
Doctor Y. Matsunaga (Sakai, JP)
Abstract Slides Video
Presentation thumbnail
Geranylgeranylacetone as prevention for postoperative Atrial Fibrillation (GENIALITY trial)
Doctor K. Silva Ramos (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Prediction of atrial fibrillation recurrences: still a challenge

The Event

Event poster

ESC Congress 2025

29 August 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Sequencing in over 120,000 cases unveils the rare coding variant architecture of atrial fibrillation
thumbnail
Congress Presentation
Creating a pipeline to extract genetic variants associated with atrial fibrillation to use in large, multi-ethnic management registries
thumbnail
Congress Presentation
Markers of atrial myopathy in the UK Biobank: prevalence, consequences, and risk stratification

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources